PMEF
VNRX icon

Point72 Middle East FZE’s VolitionRx Ltd VNRX Stock Holding History

Point72 Middle East FZE’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9
Closed -$353 – 2093
2023
Q1 		$353 Buy
+9
New +$377 ﹤0.01% 1563

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Point72 Middle East FZE's VNRX Position: Q2 2023 in Review

Point72 Middle East FZE sold out of VolitionRx Ltd (VNRX) in Q2 2023, closing a stake of 9 shares — an estimated $353 sold.

Point72 Middle East FZE first reported a position in VNRX in Q1 2023 and held it in 1 quarter. The position peaked at $353 in Q1 2023. 34 funds tracked by Wall St. Rank hold VNRX as of Q2 2023.

  • Point72 Middle East FZE reported no remaining VolitionRx Ltd position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 9 VolitionRx Ltd shares in Q2 2023, an estimated $353.
  • Point72 Middle East FZE first reported a position in VolitionRx Ltd in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's VolitionRx Ltd position peaked at $353 in Q1 2023.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.